SDF-1 binding nucleic acids

US8314223B2 · kind B2 · utility

Assignee

• NOXXON Pharma AG · DE

Inventors

• Werner Purschke · Berlin, DE
• Florian Jarosch · Berlin, DE
• Dirk Eulberg · Berlin, DE
• Sven Klussmann · Berlin, DE
• Klaus Buchner · Schaffhausen, CH
• Christian Maasch · Berlin, DE
• Nicole Dinse · Berlin, DE

Key dates

• Filing date: Jan 18, 2009
• Grant date: Nov 20, 2012
• Expiry date: Sep 2, 2030

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2320/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention is related to a nucleic acid molecule, preferably binding to SDF-1, selected from the group comprising type A nucleic acid molecules, type B nucleic acid molecules, type C nucleic acid molecules and nucleic acid molecules having a nucleic acid sequence according to any of SEQ ID NO:142, SEQ ID NO:143 or SEQ ID NO:144.